サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1537072

メソセラピー市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2033年

Mesotherapy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 175 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
メソセラピー市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2033年
出版日: 2024年08月14日
発行: Persistence Market Research
ページ情報: 英文 175 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Researchはこのほど、世界のメソセラピー市場に関する包括的なレポートを発表しました。当レポートでは、促進要因・動向・機会・課題など、重要な市場ダイナミクスを詳細に分析し、市場構造に関する詳細な洞察を提供しています。

主要な洞察

  • メソセラピー市場規模（2024年）：5億1,361万5,400米ドル
  • 市場予測金額（2033年）：15億110万米ドル
  • 世界市場成長率（CAGR 2024年～2033年）：12.7%

メソセラピー市場：調査範囲

メソセラピーは、ビタミン、酵素、ホルモン、植物抽出物を皮膚の中胚葉層に微量注射することで、皮膚の若返りと引き締め、脂肪の減少を図るものです。この低侵襲の美容施術は、主に皮膚の若返り、体の輪郭形成、局所的な脂肪沈着の減少に用いられます。メソセラピー市場は、クリニック、皮膚科センター、美容外科センターなどを対象としており、注射剤や非侵襲性機器を含むさまざまな治療オプションや製品を提供しています。市場成長の促進力は、非外科的美容施術に対する需要の増加、メソセラピーの利点に対する認知度の向上、注射技術の進歩による治療結果の向上と患者の満足度です。

市場成長の促進要因：

世界のメソセラピー市場は、外科的手術に代わる非侵襲的な美容施術への選好の高まりなど、いくつかの主要因によって推進されています。皮膚の老化、局所的な脂肪蓄積、その他の美容上の懸念が男女ともに増加していることが、メソセラピー治療の需要に寄与しています。高度なメソセラピー注射剤や併用療法の開発など、注射機器や製剤の技術的進歩が市場拡大をさらに後押ししています。さらに、可処分所得の増加、美容サービスへのアクセスの拡大、ソーシャルメディアや有名人の推薦の影響力が、市場の成長と消費者の関心を高めています。

市場抑制要因：

有望な成長見通しにもかかわらず、メソセラピー市場は安全性への懸念、規制上の問題、高額な治療費に関する課題に直面しています。打撲、腫脹、アレルギー反応などの副作用の可能性は、潜在的な患者を遠ざけるリスクとなります。メソセラピー製品と手順の承認と標準化に関連する規制上のハードルは、市場参入と運営コストに影響を与えます。さらに、メソセラピーの治療費が高額であることや保険が適用されないことから、特に医療予算に制約のある新興国では、アクセシビリティや市場浸透が制限される可能性があります。こうした問題に対処するためには、業界利害関係者が安全プロトコルを強化し、規制の明確化を提唱し、費用対効果の高い治療オプションを模索する必要があります。

市場機会：

メソセラピー市場は、技術革新、消費者の選好の進化、適用領域の拡大によって大きな成長機会をもたらしています。無針メソセラピーシステムや個別化された治療プロトコルのような先進技術の統合は、治療効果と患者の快適性を高めます。さらに、予防的な美容治療の動向の高まりや、毛髪再生やセルライト除去など従来の用途を超えたメソセラピーの応用拡大が、市場の可能性を広げています。戦略的パートナーシップ、研究開発への投資、革新的なメソセラピーソリューションの導入は、新たな機会を活用し、ダイナミックなメソセラピーの展望において市場のリーダーシップを維持するために極めて重要です。

レポートが回答する主要な質問

  • 世界のメソセラピー市場の成長を促進する主要な要因は何か？
  • さまざまなヘルスケア環境において、どのメソセラピー用途と治療タイプが採用を促進しているか？
  • 技術の進歩はメソセラピー市場の競合情勢にどのような影響を与えているか？
  • メソセラピー市場に貢献している主要企業はどこか、また市場の関連性を維持するためにどのような戦略を採用しているか？
  • 世界のメソセラピー市場の新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲 / 分類
  • 市場の定義 / 範囲 / 制限
  • 包含事項・除外事項

第3章 主要な市場動向

  • 市場に影響を与える主要な動向
  • 製品イノベーション / 開発動向

第4章 主要な成功要因

  • 採用率 / 使用状況分析 - 主要統計
  • バリューチェーン分析
  • 主要な規制 - 地域別
  • 製品のUSP分析
  • 最近の製品承認
  • PESTEL分析
  • ポーターの分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因 - 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • COVID-19と影響分析
    • 製品別
    • 適応症別
    • 流通チャネル別
    • 地域別
  • 2023年の市場シナリオ

第7章 世界市場の数量（ユニット）分析

  • 過去の市場数量（ユニット）分析、2019年～2023年
  • 現在および将来の市場規模（ユニット）予測、2024年～2033年
    • 前年比成長動向分析

第8章 世界市場 - 価格分析

  • 域別価格分析：製品別
  • 価格の内訳
    • メーカーレベルの価格設定
    • ディストリビューターレベルの価格設定
  • 世界平均価格分析ベンチマーク
  • 価格設定の前提条件

第9章 世界市場の需要（金額百万米ドル）分析

  • 過去の市場金額（百万米ドル）分析、2019年～2023年
  • 現在および将来の市場金額（百万米ドル）予測、2024年～2033年
    • 前年比成長動向分析
    • 絶対額の機会分析

第10章 世界市場分析：製品別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）と数量（ユニット）分析：製品別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）と数量（ユニット）の分析と予測：製品別、2024年～2033年
    • メソセラピーフィラーキット
    • メソセラピーソリューションキット
    • メソセラピーケミカルピーリング
    • アンチエイジングマスク
    • メソセラピークリーム
    • メソセラピースプレー
  • 市場の魅力分析：製品別

第11章 世界市場分析：適応症別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）分：適応症別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）の分析と予測：適応症別、2024年～2033年
    • アンチエイジング
    • 顔の若返り
    • しわ治療
    • ストレッチマーク
    • ニキビと傷跡の治療
    • 脂肪減少
    • 脱毛症
    • その他
  • 市場の魅力分析：適応症別

第12章 世界市場分析：流通チャネル別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）分析：適応症別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）の分析と予測：流通チャネル別、2024年～2033年
    • 病院
    • 皮膚科クリニック
    • 美容クリニック
    • オンライン販売
    • その他
  • 市場の魅力分析：流通チャネル別

第13章 世界市場分析：地域別

  • イントロダクション
  • 過去の市場規模（百万米ドル）と数量（ユニット）の分析：地域別、2019年～2023年
  • 現在および将来の市場金額（百万米ドル）と数量（ユニット）の分析と予測：地域別、2024年～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ（MEA）
  • 市場の魅力分析：地域別

第14章 北米市場分析

第15章 ラテンアメリカ市場分析

第16章 欧州市場分析

第17章 東アジア市場分析

第18章 南アジア市場分析

第19章 オセアニア市場

第20章 中東・アフリカ（MEA）市場分析

第21章 市場構造分析

  • 市場分析：企業階層別
  • 主要企業の市場シェア分析
  • 市場集中
  • 市場プレゼンス分析

第22章 競合分析

  • 競合ダッシュボード
  • 競合の詳細情報
    • Laboratoires FILORGA SA
    • INSTITUTE BCN
    • Mesoskinline
    • Koru Pharmaceuticals Co., Ltd.
    • Fusion Meso
    • TOSKANI COSMETICS
    • Dr. Korman Laboratories Ltd.
    • Ostar Beauty Sci-Tech Co Ltd.
    • Aemesso USA Corp
    • Perse Belle
    • Dermo Aroma
    • Pluryal
    • Messoessence
    • Novaderm
    • Dermaqual
    • Allergan
    • Maypharm

第23章 使用される前提条件と頭字語

第24章 調査手法

目次
Product Code: PMRREP30409

Persistence Market Research has recently released a comprehensive report on the global mesotherapy market. The report offers an in-depth analysis of critical market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Mesotherapy Market Size (2024E): USD 513.6154 million
  • Projected Market Value (2033F): USD 1501.1 million
  • Global Market Growth Rate (CAGR 2024 to 2033): 12.7%

Mesotherapy Market - Report Scope:

Mesotherapy involves delivering a series of microinjections of vitamins, enzymes, hormones, and plant extracts into the mesoderm layer of the skin to rejuvenate and tighten skin, as well as to reduce fat. This minimally invasive cosmetic procedure is primarily used for skin rejuvenation, body contouring, and reducing localized fat deposits. The mesotherapy market caters to clinics, dermatology centers, and cosmetic surgery centers, offering a range of treatment options and products, including injectables and non-invasive devices. Market growth is driven by increasing demand for non-surgical cosmetic procedures, rising awareness about mesotherapy benefits, and advancements in injection technologies, enhancing treatment outcomes and patient satisfaction.

Market Growth Drivers:

The global mesotherapy market is propelled by several key factors, including a growing preference for non-invasive cosmetic procedures as an alternative to surgical interventions. The increasing incidence of skin aging, localized fat accumulation, and other aesthetic concerns among both men and women contributes to the demand for mesotherapy treatments. Technological advancements in injection devices and formulations, such as the development of advanced mesotherapy injectables and combination therapies, further drive market expansion. Additionally, rising disposable incomes, greater access to cosmetic services, and the influence of social media and celebrity endorsements boost market growth and consumer interest.

Market Restraints:

Despite promising growth prospects, the mesotherapy market faces challenges related to safety concerns, regulatory issues, and high treatment costs. Potential side effects, such as bruising, swelling, and allergic reactions, pose risks that may deter potential patients. Regulatory hurdles related to the approval and standardization of mesotherapy products and procedures impact market entry and operational costs. Moreover, the high cost of mesotherapy treatments and the lack of insurance coverage can limit accessibility and market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these issues requires industry stakeholders to enhance safety protocols, advocate for regulatory clarity, and explore cost-effective treatment options.

Market Opportunities:

The mesotherapy market presents significant growth opportunities driven by technological innovations, evolving consumer preferences, and expanding application areas. The integration of advanced technologies, such as needle-free mesotherapy systems and personalized treatment protocols, enhances treatment efficacy and patient comfort. Furthermore, the growing trend of preventive aesthetic treatments and the expansion of mesotherapy applications beyond traditional uses, such as in hair restoration and cellulite reduction, broaden market potential. Strategic partnerships, investment in research and development, and the introduction of innovative mesotherapy solutions are crucial to capitalizing on emerging opportunities and sustaining market leadership in the dynamic mesotherapy landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the mesotherapy market globally?
  • Which mesotherapy applications and treatment types are driving adoption across different healthcare settings?
  • How are technological advancements influencing the competitive landscape of the mesotherapy market?
  • Who are the key players contributing to the mesotherapy market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global mesotherapy market?

Competitive Intelligence and Business Strategy:

Leading players in the global mesotherapy market, including Allergan plc, Galderma S.A., and Revance Therapeutics, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced mesotherapy solutions, including new injectables, needle-free systems, and combination therapies, catering to diverse patient needs and clinical requirements. Collaborations with cosmetic clinics, dermatologists, and research institutions facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving mesotherapy landscape.

Key Companies Profiled:

  • Laboratories FILORGO SA
  • INSTITUTE BCN
  • mesoskinline
  • Koru Pharmaceuticals Co., Ltd.
  • Fusion Meso
  • TOSKANI COSMETICS
  • Dr. Korman Laboratories Ltd.
  • Ostar Beauty Sci-Tech Co Ltd.
  • Aemesso U.S.A. Corp
  • Perse Belle
  • Dermo Aroma
  • Pluryal
  • Messoessence
  • Novaderm
  • Dermaqual
  • Allergan
  • Maypharm
  • Galderma Laboratories

Key Segments Covered in Mesotherapy Industry Research

Product:

  • Mesotherapy Fillers Kits
  • Mesotherapy Solutions Kits
  • Mesotherapy Chemical Peels
  • Anti-ageing Masks
  • Mesotherapy Creams
  • Mesotherapy Spray

Indication:

  • Anti-ageing
  • Facial Rejuvenation
  • Wrinkle Treatment
  • Stretch marks
  • Acne & Scar Treatment
  • Fat Loss
  • Hair Loss/Alopecia

Distribution Channel:

  • Hospitals
  • Dermatology Clinics
  • Cosmetic Clinics
  • Online Sales

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Adoption Rate/Usage Analysis - Key Statistics
  • 4.2. Value Chain Analysis
  • 4.3. Key Regulations - By Region
  • 4.4. Product USP Analysis
  • 4.5. Recent Product Approvals
  • 4.6. PESTEL Analysis
  • 4.7. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Dermatology Market Outlook
  • 5.2. Forecast Factors - Relevance and Impact
    • 5.2.1. Increasing Prevalence of Skin Disease
    • 5.2.2. Rising Prevalence of Skincare
    • 5.2.3. Increased Mergers and Acquisitions
    • 5.2.4. Innovation and Development
    • 5.2.5. New Advancements in Treatment
    • 5.2.6. Regulatory Approvals
    • 5.2.7. Research and Development for New Drugs
    • 5.2.8. Technological Advancements
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Indication
    • 6.1.3. By Distribution Channel
    • 6.1.4. By Region
  • 6.2. 2023 Market Scenario

7. Global Market Volume (Units) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By Product
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Market Demand (in Value US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2024-2033
    • 10.3.1. Mesotherapy Fillers Kits
    • 10.3.2. Mesotherapy Solutions Kits
    • 10.3.3. Mesotherapy Chemical Peels
    • 10.3.4. Anti-ageing Masks
    • 10.3.5. Mesotherapy Creams
    • 10.3.6. Mesotherapy Spray
      • 10.3.6.1. Mesotherapy Devices
      • 10.3.6.2. Microneedling Pens
      • 10.3.6.3. Dermarollers
      • 10.3.6.4. Injection Guns
      • 10.3.6.5. Mesotherapy Needles and Cannulas
      • 10.3.6.6. Skin Analyzers
  • 10.4. Market Attractiveness Analysis, By Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Indication

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Indication, 2024-2033
    • 11.3.1. Anti-ageing
    • 11.3.2. Facial Rejuvenation
    • 11.3.3. Wrinkle Treatment
    • 11.3.4. Stretch marks
    • 11.3.5. Acne and Scar Treatment
    • 11.3.6. Fat Loss
    • 11.3.7. Hair Loss/Alopecia
    • 11.3.8. Others
  • 11.4. Market Attractiveness Analysis, By Indication

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Distribution Channel

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis, By Indication, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2024-2033
    • 12.3.1. Hospitals
    • 12.3.2. Dermatology Clinics
    • 12.3.3. Cosmetic Clinics
    • 12.3.4. Online Sales
    • 12.3.5. Others
  • 12.4. Market Attractiveness Analysis, By Distribution Channel

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Region, 2019-2023
  • 13.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2024-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis, by Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product
    • 14.3.3. By Indication
    • 14.3.4. By Distribution Channel
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Indication
    • 14.4.4. By Distribution Channel
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis and Forecast
    • 14.8.1. U.S. Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Indication
        • 14.8.1.2.3. By Distribution Channel
    • 14.8.2. Canada Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Indication
        • 14.8.2.2.3. By Distribution Channel

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Mexico
      • 15.3.1.2. Brazil
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product
    • 15.3.3. By Indication
    • 15.3.4. By Distribution Channel
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Indication
    • 15.4.4. By Distribution Channel
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis and Forecast
    • 15.8.1. Mexico Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Indication
        • 15.8.1.2.3. By Distribution Channel
    • 15.8.2. Brazil Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Indication
        • 15.8.2.2.3. By Distribution Channel
    • 15.8.3. Argentina Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Indication
        • 15.8.3.2.3. By Distribution Channel

16. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Russia
      • 16.3.1.8. Rest of Europe
    • 16.3.2. By Product
    • 16.3.3. By Indication
    • 16.3.4. By Distribution Channel
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Indication
    • 16.4.4. By Distribution Channel
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis and Forecast
    • 16.8.1. Germany Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Indication
        • 16.8.1.2.3. By Distribution Channel
    • 16.8.2. Italy Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Indication
        • 16.8.2.2.3. By Distribution Channel
    • 16.8.3. France Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Indication
        • 16.8.3.2.3. By Distribution Channel
    • 16.8.4. U.K. Market Analysis
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.4.2.1. By Product
        • 16.8.4.2.2. By Indication
        • 16.8.4.2.3. By Distribution Channel
    • 16.8.5. Spain Market Analysis
      • 16.8.5.1. Introduction
      • 16.8.5.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.5.2.1. By Product
        • 16.8.5.2.2. By Indication
        • 16.8.5.2.3. By Distribution Channel
    • 16.8.6. BENELUX Market Analysis
      • 16.8.6.1. Introduction
      • 16.8.6.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.6.2.1. By Product
        • 16.8.6.2.2. By Indication
        • 16.8.6.2.3. By Distribution Channel
    • 16.8.7. Russia Market Analysis
      • 16.8.7.1. Introduction
      • 16.8.7.2. Market Analysis and Forecast, by Market Taxonomy
        • 16.8.7.2.1. By Product
        • 16.8.7.2.2. By Indication
        • 16.8.7.2.3. By Distribution Channel

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Product
    • 17.3.3. By Indication
    • 17.3.4. By Distribution Channel
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Product
    • 17.4.2. By Indication
    • 17.4.3. By Distribution Channel
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis and Forecast
    • 17.8.1. China Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Indication
        • 17.8.1.2.3. By Distribution Channel
    • 17.8.2. Japan Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Indication
        • 17.8.2.2.3. By Distribution Channel
    • 17.8.3. South Korea Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Indication
        • 17.8.3.2.3. By Distribution Channel

18. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. India
      • 18.3.1.2. Indonesia
      • 18.3.1.3. Malaysia
      • 18.3.1.4. Thailand
      • 18.3.1.5. Rest of South Asia
    • 18.3.2. By Product
    • 18.3.3. By Indication
    • 18.3.4. By Distribution Channel
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Indication
    • 18.4.4. By Distribution Channel
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis and Forecast
    • 18.8.1. India Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Indication
        • 18.8.1.2.3. By Distribution Channel
    • 18.8.2. Indonesia Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Indication
        • 18.8.2.2.3. By Distribution Channel
    • 18.8.3. Malaysia Market Analysis
      • 18.8.3.1. Introduction
      • 18.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.8.3.2.1. By Product
        • 18.8.3.2.2. By Indication
        • 18.8.3.2.3. By Distribution Channel
    • 18.8.4. Thailand Market Analysis
      • 18.8.4.1. Introduction
      • 18.8.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 18.8.4.2.1. By Product
        • 18.8.4.2.2. By Indication
        • 18.8.4.2.3. By Distribution Channel

19. Oceania Market 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product
    • 19.3.3. By Indication
    • 19.3.4. By Distribution Channel
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Indication
    • 19.4.4. By Distribution Channel
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Country Level Analysis and Forecast
    • 19.8.1. Australia Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By Indication
        • 19.8.1.2.3. By Distribution Channel
    • 19.8.2. New Zealand Market Analysis
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By Indication
        • 19.8.2.2.3. By Distribution Channel

20. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Value (US$ Mn) and Volume (Units) Analysis and Forecast, by Market Taxonomy, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkiye
      • 20.3.1.3. South Africa
      • 20.3.1.4. North Africa
      • 20.3.1.5. Rest of Middle East and Africa
    • 20.3.2. By Product
    • 20.3.3. By Indication
    • 20.3.4. By Distribution Channel
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Product
    • 20.4.2. By Indication
    • 20.4.3. By Distribution Channel
  • 20.5. Market Trends
  • 20.6. Key Market Participants - Intensity Mapping
  • 20.7. Drivers and Restraints - Impact Analysis
  • 20.8. Country Level Analysis and Forecast
    • 20.8.1. GCC Countries Market Analysis
      • 20.8.1.1. Introduction
      • 20.8.1.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.8.1.2.1. By Product
        • 20.8.1.2.2. By Indication
        • 20.8.1.2.3. By Distribution Channel
    • 20.8.2. Turkiye Market Analysis
      • 20.8.2.1. Introduction
      • 20.8.2.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.8.2.2.1. By Product
        • 20.8.2.2.2. By Indication
        • 20.8.2.2.3. By Distribution Channel
    • 20.8.3. South Africa Market Analysis
      • 20.8.3.1. Introduction
      • 20.8.3.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.8.3.2.1. By Product
        • 20.8.3.2.2. By Indication
        • 20.8.3.2.3. By Distribution Channel
    • 20.8.4. North Africa Market Analysis
      • 20.8.4.1. Introduction
      • 20.8.4.2. Market Analysis and Forecast, by Market Taxonomy
        • 20.8.4.2.1. By Product
        • 20.8.4.2.2. By Indication
        • 20.8.4.2.3. By Distribution Channel

21. Market Structure Analysis

  • 21.1. Market Analysis, by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Concentration
  • 21.4. Market Presence Analysis
    • 21.4.1. By Regional Footprints of Players
    • 21.4.2. By Product Footprints of Players
    • 21.4.3. By Channel Footprints of Players

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Deep Dive
    • 22.2.1. Laboratoires FILORGA SA
      • 22.2.1.1. Overview
      • 22.2.1.2. Product Portfolio
      • 22.2.1.3. Sales Footprint
      • 22.2.1.4. Key Financials
      • 22.2.1.5. SWOT Analysis
      • 22.2.1.6. Strategy Overview
        • 22.2.1.6.1. Marketing Strategy
        • 22.2.1.6.2. Product Strategy
        • 22.2.1.6.3. Channel Strategy
    • 22.2.2. INSTITUTE BCN
      • 22.2.2.1. Overview
      • 22.2.2.2. Product Portfolio
      • 22.2.2.3. Sales Footprint
      • 22.2.2.4. Key Financials
      • 22.2.2.5. SWOT Analysis
      • 22.2.2.6. Strategy Overview
        • 22.2.2.6.1. Marketing Strategy
        • 22.2.2.6.2. Product Strategy
        • 22.2.2.6.3. Channel Strategy
    • 22.2.3. Mesoskinline
      • 22.2.3.1. Overview
      • 22.2.3.2. Product Portfolio
      • 22.2.3.3. Sales Footprint
      • 22.2.3.4. Key Financials
      • 22.2.3.5. SWOT Analysis
      • 22.2.3.6. Strategy Overview
        • 22.2.3.6.1. Marketing Strategy
        • 22.2.3.6.2. Product Strategy
        • 22.2.3.6.3. Channel Strategy
    • 22.2.4. Koru Pharmaceuticals Co., Ltd.
      • 22.2.4.1. Overview
      • 22.2.4.2. Product Portfolio
      • 22.2.4.3. Sales Footprint
      • 22.2.4.4. Key Financials
      • 22.2.4.5. SWOT Analysis
      • 22.2.4.6. Strategy Overview
        • 22.2.4.6.1. Marketing Strategy
        • 22.2.4.6.2. Product Strategy
        • 22.2.4.6.3. Channel Strategy
    • 22.2.5. Fusion Meso
      • 22.2.5.1. Overview
      • 22.2.5.2. Product Portfolio
      • 22.2.5.3. Sales Footprint
      • 22.2.5.4. Key Financials
      • 22.2.5.5. SWOT Analysis
      • 22.2.5.6. Strategy Overview
        • 22.2.5.6.1. Marketing Strategy
        • 22.2.5.6.2. Product Strategy
        • 22.2.5.6.3. Channel Strategy
    • 22.2.6. TOSKANI COSMETICS
      • 22.2.6.1. Overview
      • 22.2.6.2. Product Portfolio
      • 22.2.6.3. Sales Footprint
      • 22.2.6.4. Key Financials
      • 22.2.6.5. SWOT Analysis
      • 22.2.6.6. Strategy Overview
        • 22.2.6.6.1. Marketing Strategy
        • 22.2.6.6.2. Product Strategy
        • 22.2.6.6.3. Channel Strategy
    • 22.2.7. Dr. Korman Laboratories Ltd.
      • 22.2.7.1. Overview
      • 22.2.7.2. Product Portfolio
      • 22.2.7.3. Sales Footprint
      • 22.2.7.4. Key Financials
      • 22.2.7.5. SWOT Analysis
      • 22.2.7.6. Strategy Overview
        • 22.2.7.6.1. Marketing Strategy
        • 22.2.7.6.2. Product Strategy
        • 22.2.7.6.3. Channel Strategy
    • 22.2.8. Ostar Beauty Sci-Tech Co Ltd.
      • 22.2.8.1. Overview
      • 22.2.8.2. Product Portfolio
      • 22.2.8.3. Sales Footprint
      • 22.2.8.4. Key Financials
      • 22.2.8.5. SWOT Analysis
      • 22.2.8.6. Strategy Overview
        • 22.2.8.6.1. Marketing Strategy
        • 22.2.8.6.2. Product Strategy
        • 22.2.8.6.3. Channel Strategy
    • 22.2.9. Aemesso U.S.A. Corp
      • 22.2.9.1. Overview
      • 22.2.9.2. Product Portfolio
      • 22.2.9.3. Sales Footprint
      • 22.2.9.4. Key Financials
      • 22.2.9.5. SWOT Analysis
      • 22.2.9.6. Strategy Overview
        • 22.2.9.6.1. Marketing Strategy
        • 22.2.9.6.2. Product Strategy
        • 22.2.9.6.3. Channel Strategy
    • 22.2.10. Perse Belle
      • 22.2.10.1. Overview
      • 22.2.10.2. Product Portfolio
      • 22.2.10.3. Sales Footprint
      • 22.2.10.4. Key Financials
      • 22.2.10.5. SWOT Analysis
      • 22.2.10.6. Strategy Overview
        • 22.2.10.6.1. Marketing Strategy
        • 22.2.10.6.2. Product Strategy
        • 22.2.10.6.3. Channel Strategy
    • 22.2.11. Dermo Aroma
      • 22.2.11.1. Overview
      • 22.2.11.2. Product Portfolio
      • 22.2.11.3. Sales Footprint
      • 22.2.11.4. Key Financials
      • 22.2.11.5. SWOT Analysis
      • 22.2.11.6. Strategy Overview
        • 22.2.11.6.1. Marketing Strategy
        • 22.2.11.6.2. Product Strategy
        • 22.2.11.6.3. Channel Strategy
    • 22.2.12. Pluryal
      • 22.2.12.1. Overview
      • 22.2.12.2. Product Portfolio
      • 22.2.12.3. Sales Footprint
      • 22.2.12.4. Key Financials
      • 22.2.12.5. SWOT Analysis
      • 22.2.12.6. Strategy Overview
        • 22.2.12.6.1. Marketing Strategy
        • 22.2.12.6.2. Product Strategy
        • 22.2.12.6.3. Channel Strategy
    • 22.2.13. Messoessence
      • 22.2.13.1. Overview
      • 22.2.13.2. Product Portfolio
      • 22.2.13.3. Sales Footprint
      • 22.2.13.4. Key Financials
      • 22.2.13.5. SWOT Analysis
      • 22.2.13.6. Strategy Overview
        • 22.2.13.6.1. Marketing Strategy
        • 22.2.13.6.2. Product Strategy
        • 22.2.13.6.3. Channel Strategy
    • 22.2.14. Novaderm
      • 22.2.14.1. Overview
      • 22.2.14.2. Product Portfolio
      • 22.2.14.3. Sales Footprint
      • 22.2.14.4. Key Financials
      • 22.2.14.5. SWOT Analysis
      • 22.2.14.6. Strategy Overview
        • 22.2.14.6.1. Marketing Strategy
        • 22.2.14.6.2. Product Strategy
        • 22.2.14.6.3. Channel Strategy
    • 22.2.15. Dermaqual
      • 22.2.15.1. Overview
      • 22.2.15.2. Product Portfolio
      • 22.2.15.3. Sales Footprint
      • 22.2.15.4. Key Financials
      • 22.2.15.5. SWOT Analysis
      • 22.2.15.6. Strategy Overview
        • 22.2.15.6.1. Marketing Strategy
        • 22.2.15.6.2. Product Strategy
        • 22.2.15.6.3. Channel Strategy
    • 22.2.16. Allergan
      • 22.2.16.1. Overview
      • 22.2.16.2. Product Portfolio
      • 22.2.16.3. Sales Footprint
      • 22.2.16.4. Key Financials
      • 22.2.16.5. SWOT Analysis
      • 22.2.16.6. Strategy Overview
        • 22.2.16.6.1. Marketing Strategy
        • 22.2.16.6.2. Product Strategy
        • 22.2.16.6.3. Channel Strategy
    • 22.2.17. Maypharm
      • 22.2.17.1. Overview
      • 22.2.17.2. Product Portfolio
      • 22.2.17.3. Sales Footprint
      • 22.2.17.4. Key Financials
      • 22.2.17.5. SWOT Analysis
      • 22.2.17.6. Strategy Overview
        • 22.2.17.6.1. Marketing Strategy
        • 22.2.17.6.2. Product Strategy
        • 22.2.17.6.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology